These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17883112)

  • 1. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
    Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
    Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
    Kimura T; Budka H; Soler-Federsppiel S
    Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
    Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
    Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA; Morrison AL
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
    Ikota H; Kinjo S; Yokoo H; Nakazato Y
    Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
    Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
    Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin expression in astrocytic tumors delineates tumor infiltration.
    Kitai R; Horita R; Sato K; Yoshida K; Arishima H; Higashino Y; Hashimoto N; Takeuchi H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2010 Apr; 27(1):17-21. PubMed ID: 20425043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
    Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
    Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of expression of TSC-22 protein in astrocytic gliomas.
    Shostak KO; Dmitrenko VV; Vudmaska MI; Naidenov VG; Beletskii AV; Malisheva TA; Semenova VM; Zozulya YP; Demotes-Mainard J; Kavsan VM
    Exp Oncol; 2005 Dec; 27(4):314-8. PubMed ID: 16404353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliosarcoma: a histologic and immunohistochemical reaffirmation.
    Meis JM; Ho KL; Nelson JS
    Mod Pathol; 1990 Jan; 3(1):19-24. PubMed ID: 2155418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of immunohistochemistry to the differential diagnosis of primary and metastatic neoplasma of the central nervous system (CNS).
    Markaki S; Prevedorou D; Georgoulakis G; Bouja J; Karabela-Bouropoulou V
    Arch Anat Cytol Pathol; 1989; 37(3):93-8. PubMed ID: 2751365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.